Parkinson’s Disease Research News

Share on FacebookTweet about this on Twitter

Newsfeed:

  • The Acorda’s Tozadenant Phase III clinical trials
    The biotech company Acorda Therapeutics Inc. yesterday announced that it was halting new recruitment for the phase III program of its drug Tozadenant (an oral adenosine A2a receptor antagonist). In addition, participants currently enrolled in the trial will now have their blood monitoring conducted on a weekly basis.  The ... read more
    Source: The Science of Parkinson’s diseasePublished on 2017-11-16By Simon
  • Intervention Becomes First to Successfully Reduce Dementia Risk
    Researchers report a computerized brain training intervention may reduce dementia risks in the elderly. ... read more
    Source: Neuro Science NewsPublished on 2017-11-16By Neuroscience News
  • Nanowired Drugs Could Treat Alzheimer’s and Parkinson’s Patients
    Using titanate nanowires treated with cerebrolysin, researchers have been able to target delivery to the brain and through the central nervous system. Researchers report the use of nanowires to deliver drugs could be beneficial in the treatment of Alzheimer's, Parkinson's and other neurodegenerative diseases. ... read more
    Source: Neuro Science NewsPublished on 2017-11-16By Neuroscience News
  • How bacteria in the gut influence neurodegenerative disorders
    Humans have roughly as many bacterial cells in their bodies as human cells, and most of those bacteria live in the gut. New research released today reveals links between the gut microbiome -- the population of microorganisms living in the gastrointestinal tract -- and brain diseases such as Parkinson's and ... read more
    Source: Science DailyPublished on 2017-11-16
  • Editorial: Orphan drug tax credit
    Here at the SoPD we are politically neutral. That said, I will report on events that directly impact the world of Parkinson’s disease research (without adding too much in the way of personal opinions).  Recent legislation introduced in the US congress could have major implications for subsets of the Parkinson’s ... read more
    Source: The Science of Parkinson’s diseasePublished on 2017-11-14By Simon
  • How Gut Bacteria Influences Neurodegenerative Disorders
    Researchers recently presented new findings linking gut bacteria to neurodegenerative diseases at Neuroscience 2017. Findings suggest better understanding of the microbiome could lead to better treatments for Alzheimer's and Parkinson's. ... read more
    Source: Neuro Science NewsPublished on 2017-11-14By Neuroscience News
  • Defects in cell’s ‘waste disposal system’ linked to Parkinson’s
    Research points at a group of lysosomal storage disorder genes as potential major contributors to the onset and progression of Parkinson's disease. ... read more
    Source: Science DailyPublished on 2017-11-14
  • Defects in cell’s ‘waste disposal system’ linked to Parkinson’s
    (Baylor College of Medicine) Research points at a group of lysosomal storage disorder genes as potential major contributors to the onset and progression of Parkinson's disease. ... read more
    Source: Eureka AlertPublished on 2017-11-14
  • Parkinson’s Disease: A Looming Pandemic
    Researchers predict the number of people diagnosed with Parkinson's disease will grow to pandemic proportions by 2040. ... read more
    Source: Neuro Science NewsPublished on 2017-11-13By Neuroscience News
  • Parkinson’s disease: A looming pandemic
    The number of people with Parkinson's disease will soon grow to pandemic proportions, research concludes. In a new article, researchers argue that the medical community must be mobilized to respond to this impending public health threat. ... read more
    Source: Science DailyPublished on 2017-11-13
  • Deadly Combination in Neurodegenerative Diseases Revealed
    A new mouse model has been developed that captures the pathology of sporadic neurodegenerative diseases. ... read more
    Source: Neuro Science NewsPublished on 2017-11-13By Neuroscience News
  • Parkinson’s disease: A looming pandemic
    (University of Rochester Medical Center) New research shows that the number of people with Parkinson's disease will soon grow to pandemic proportions. In a commentary appearing today in the journal JAMA Neurology, University of Rochester Medical Center neurologist Ray Dorsey, M.D. and Bastiaan Bloem, M.D., Ph.D., with Radboud University Medical ... read more
    Source: Eureka AlertPublished on 2017-11-13
  • James: The man behind the disease (Part 3)
    This post is the third in our four part series on the life of Mr James Parkinson, in observance of 200 years since his first description of Parkinson’s disease. Here we will look at the bulk of James’ adult life – not only his medical related activities, but also all of the ... read more
    Source: The Science of Parkinson’s diseasePublished on 2017-11-11By Simon
  • How to Control Traffic on Cellular Highways
    Findings from Rutgers researchers may help to develop new treatments for spinal cord injuries and neurodegenerative diseases. ... read more
    Source: Neuro Science NewsPublished on 2017-11-10By Neuroscience News
  • Biomarker may predict early Alzheimer’s disease
    (Sanford-Burnham Prebys Medical Discovery Institute) Researchers at SBP have identified a peptide that could lead to the early detection of Alzheimer's disease (AD). The discovery, published in Nature Communications, may also provide a means of homing drugs to diseased areas of the brain to treat AD, Parkinson's disease, as well ... read more
    Source: Eureka AlertPublished on 2017-11-10
  • New research to target air pollution as a potential trigger for Parkinson’s
    (Van Andel Research Institute) The Department of Defense has awarded a multi-institutional team of scientists a series of grants totaling $4.37 million to investigate the potential role of airborne pollutants as triggers of Parkinson's disease via the nose. ... read more
    Source: Eureka AlertPublished on 2017-11-09
  • Licorice Extract May Help Prevent and Treat Parkinson’s
    According to a new study, liquiritigenin, a licorice extract, may help to inhibit dopaminergic neuronal cell death and could help slow the progression of Parkinson's disease. ... read more
    Source: Neuro Science NewsPublished on 2017-11-08By Neuroscience News
  • The LRRK Ascending
    Genetic mutations (or ‘variants’) in the Leucine-rich repeat kinase 2 (or LRRK2; also known as Dardarin) gene are associated with increased risk of Parkinson’s. As a result this gene has become the focus of a lot of genetic research. But what about LRRK2’s less well-known, rather neglected sibling LRRK1? In ... read more
    Source: The Science of Parkinson’s diseasePublished on 2017-11-07By Simon
  • New possibility to prevent and treat Parkinson’s disease with licorice extract
    (DGIST (Daegu Gyeongbuk Institute of Science and Technology)) Researchers in Korea newly found the mechanism of inhibition of dopamine neuronal cell death using licorice extract 'liquiritigenin'. It scientifically proves the possibility of treating degenerative brain diseases using natural materials. ... read more
    Source: Eureka AlertPublished on 2017-11-07
  • New treatment direction sought in Parkinson’s by blocking the blocker of a natural protection
    (Medical College of Georgia at Augusta University) Oxidative stress plays a big role in the brain cell loss that occurs in Parkinson's disease. Now scientists have their sights on a protein that inhibits one of the body's natural protections against it. ... read more
    Source: Eureka AlertPublished on 2017-11-06
  • CRISPR-Cas9: “New CRISPY Parkinson’s research”
    Recently a Parkinson’s-associated research report was published that was the first of many to come. It involves the use of a genetic screening experiment that incorporates new technology called ‘CRISPR’. There is an absolute tidal wave of CRISPR-related Parkinson’s disease research coming down the pipe towards us, ... read more
    Source: The Science of Parkinson’s diseasePublished on 2017-11-05By Simon
  • Gut Bacteria Linked to Age Related Conditions
    Researchers transplanted gut bacteria from older mice into young mice and noted age related chronic inflammation following the procedure. The process, dubbed inflammaging, is linked to conditions associated with older age such as stoke and dementia. ... read more
    Source: Neuro Science NewsPublished on 2017-11-05By Neuroscience News
  • Scratching the surface of mature monocytes…and coming up with CXCR7
    (Federation of American Societies for Experimental Biology) New research published online in the Journal of Leukocyte Biology showed for the first time that mature monocytes (a specific type of white blood cell) express the CXCR7 receptor on their surface. This receptor may be a therapeutic target for controlling inflammation in ... read more
    Source: Eureka AlertPublished on 2017-11-03
  • Should patients be asleep or awake during brain surgery?
    (Oregon Health & Science University) Deep brain stimulation eases the effects of Parkinson's disease and tremor. A new study indicates no demonstrable difference in clinical outcomes between patients who underwent the implantation under general anesthesia versus those who went through it while awake. ... read more
    Source: Eureka AlertPublished on 2017-11-01
  • Brain’s Response to Mid-Life Surge in Cell Aging Starts or Ends Path to Dementia
    University of Texas researchers report neurons in the mouse brain tend to surge at the equivalent of human age 40. During this period, interleukin33 also surges in healthy mice. In those lacking the gene, neurodegeneration occurred, eventually resulting in dementia. ... read more
    Source: Neuro Science NewsPublished on 2017-10-30By Neuroscience News
1 2 3 31